Post-Market Study of Low-flow ECCO2R Using PrismaLung+

NCT04617093 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Acute Respiratory Distress Syndrome

Interventions

DEVICE: PrismaLung+

Sponsor

Vantive Health LLC

Collaborators

[object Object]